Rankings / Cognitive

Pitolisant (Wakix)

Cognitive · H3 receptor inverse agonist

Tier B+

prescription
7.4 / 10
Tier B+
Ev 8 Bn 6.5 Sf 7

Bottom line

Read Off Label grades Pitolisant (Wakix) as B+ (7.4/10) based on strong evidence, moderate-strong benefit magnitude, and a low-med-risk safety profile.

Harmony Biosciences; brand Wakix.

Typical use: 17. — Rx.

What this is

Harmony Biosciences; brand Wakix. FDA-approved 2019 for narcolepsy. The non-controlled status is the key differentiator — uniquely accessible without DEA scheduling concerns. Clinical effect somewhat smaller than modafinil/solriamfetol but unique mechanism makes it complementary rather than redundant.

Mechanism

Histamine H3 receptor inverse agonist/antagonist — increases endogenous histamine release in tuberomammillary nucleus → cortical wakefulness; non-controlled, non-amphetamine mechanism

Dose & route

17.8-35.6 mg PO once daily morning

Common questions

Does Pitolisant (Wakix) work?
Read Off Label rates the evidence for Pitolisant (Wakix) as Strong and the benefit magnitude as moderate-strong, producing an overall grade of B+ (7.4/10). Harmony Biosciences; brand Wakix.
Is Pitolisant (Wakix) safe?
Pitolisant (Wakix) has a low-med risk profile in published human data. Legal status: Rx (NOT scheduled — unique among wakefulness drugs). This is not medical advice — see the disclaimer.
What is the typical dose for Pitolisant (Wakix)?
17.8-35.6 mg PO once daily morning
How does Pitolisant (Wakix) work?
Histamine H3 receptor inverse agonist/antagonist — increases endogenous histamine release in tuberomammillary nucleus → cortical wakefulness; non-controlled, non-amphetamine mechanism

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.